Alzinova Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Public

  • Employees
  • 5

Employees

  • Stock Symbol
  • ALZ

Stock Symbol

  • Share Price
  • $0.38
  • (As of Friday Closing)

Alzinova General Information

Description

Alzinova AB is a Swedish biotechnology company engaged in the discovery and development of therapeutics for the treatment of Alzheimer's disease. The company is engaged in the development of a specific oligomer-directed vaccine (ALZ-101), and ALZ-201 which is a monoclonal antibody that is specific for the toxic AB oligomers. The products of the company are in the clinical and preclinical stages of development as a therapeutic vaccine for the treatment of Alzheimer's.

Contact Information

Website
www.alzinova.com
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Erik Dahlbergsgatan 11 A
  • 411 26 Gothenburg
  • Sweden
+46 070-428 00 00
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
STO
Corporate Office
  • Erik Dahlbergsgatan 11 A
  • 411 26 Gothenburg
  • Sweden
+46 070-428 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alzinova Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.38 $0.38 $0.07 - $0.45 $33.5M 89.2M 662K -$0.02

Alzinova Financials Summary

In Thousands,
USD 		TTM 30-Jun-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 5,040 10,513 5,092 7,327
Revenue 28 25 0 0
EBITDA (1,698) (1,554) (1,290) (876)
Net Income (1,702) (1,550) (1,290) (879)
Total Assets 10,568 12,326 10,700 10,132
Total Debt 0 80 77 88
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Alzinova Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Alzinova‘s full profile, request access.

Request a free trial

Alzinova Patents

  • 19

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 18

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Alzinova Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20130344089-A1 Anti oligomer antibodies and uses thereof Active 08-Mar-2011 000000000
EP-2497782-A1 Anti oligomer antibodies and uses thereof Inactive 08-Mar-2011 000000000 0
EP-2683738-B1 Anti oligomer antibodies and uses thereof Active 08-Mar-2011 000000000
EP-2683738-A1 Anti oligomer antibodies and uses thereof Active 08-Mar-2011 000000000
CA-2721156-A1 Stable amyloid beta monomers and oligomers Active 14-Apr-2008 C07K14/4711
To view Alzinova’s complete patent history, request access »

Alzinova Executive Team (6)

Name Title Board Seat
Kristina Torfgård Ph.D Chief Executive Officer
Håkan Skogström Chief Financial Officer
Anders Sandberg Chief Scientific Officer
Kirsten Harting Chief Medical Officer
Carol Routledge Acting Chief Executive Officer
You’re viewing 5 of 6 executive team members. Get the full list »

Alzinova Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alzinova Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Alzinova‘s full profile, request access.

Request a free trial

Ready to get started?

Request a free trial

Alzinova FAQs

  • When was Alzinova founded?

    Alzinova was founded in 2011.

  • Who is the founder of Alzinova?

    Anders Sandberg is the founder of Alzinova.

  • Who is the CEO of Alzinova?

    Kristina Torfgård Ph.D and Carol Routledge are the CEOs of Alzinova.

  • Where is Alzinova headquartered?

    Alzinova is headquartered in Gothenburg, Sweden.

  • What is the size of Alzinova?

    Alzinova has 5 total employees.

  • What industry is Alzinova in?

    Alzinova’s primary industry is Biotechnology.

  • Is Alzinova a private or public company?

    Alzinova is a Public company.

  • What is Alzinova’s stock symbol?

    The ticker symbol for Alzinova is ALZ.

  • What is the current stock price of Alzinova?

    As of 13-Sep-2024 the stock price of Alzinova is $0.38.

  • What is the current market cap of Alzinova?

    The current market capitalization of Alzinova is $33.5M.

  • What is Alzinova’s current revenue?

    The trailing twelve month revenue for Alzinova is $28.2K.

  • What is Alzinova’s annual earnings per share (EPS)?

    Alzinova’s EPS for 12 months was -$0.02.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »